Gunjan Verma - India

“If implemented by the CDSCO in the right earnest as per current rule book, it would create a lot of new steps in the import license process, including local testing requirements at BIS approved labs.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

India Telegraphs Enforcing Local BIS Standards for Medical Devices

Published on: March 12th, 2022

Implementation Would Require Some Products Pass In Country Testing

On February 1, 2022, the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, Govt. of India released a list of Bureau of Indian Standards (BIS) standards applicable to 1,485 medical devices. While not formally enforced at this time, it is expected that the Ministry of Health and Family Welfare (MOHFW) will soon begin enforcing these local standards. Manufacturers should review the recently released standards and ensure their products meet these standards if they have plans for entering the Indian market. Otherwise, in country local testing may be required as part of the Import License application process which may significantly increase costs and time to market. Manufacturers of products that would potentially require in-country testing to BIS standards should consider seeking registration as soon as possible. Additionally, all Class A and B products are required to have an Import License by October 1, 2022.

For a complete list of BIS standards, please see the CDSCO’s Public Notice here.

Implementation Status of BIS Standards

Rule 7 of Medical Device Rules 2017 specifies the requirements for Product Standards for medical devices and that medical devices should conform to the standards laid down by Bureau of Indian Standards (BIS) or the standards notified by the Ministry of Health and Family Welfare (MOHFW) in the Central Government, from time to time. If there are no relevant Standard of any medical device that has been laid down by BIS or notified by MoHFW, device shall conform to the standard laid down by the International Organisation for Standardisation (ISO) or the International Electro Technical Commission (IEC), or by any other pharmacopeial standards. And in case of the standards which have not been specified by any of the options given above, then the device shall conform to the validated manufacturer’s standards.

Rule 7. Product standards for medical device.— (1) The medical device shall conform to the standards laid down by the Bureau of Indian Standards established under section 3 of the Bureau of Indian Standards Act, 1985 (63 of 1985) or as may be notified by the Ministry of Health and Family Welfare in the Central Government, from time to time. (2) Where no relevant Standard of any medical device has been laid down under sub-rule (1), such device shall conform to the standard laid down by the International Organisation for Standardisation (ISO) or the International Electro Technical Commission (IEC), or by any other pharmacopoeial standards. (3) In case of the standards which have not been specified under sub-rule (1) and sub-rule (2), the device shall conform to the validated manufacturer’s standards.

Rule 7 Enforcement Under Consideration

Even though Rule 7 has been a part of the Indian MDR 2017 from the initial implementation in January 2018, the CDSCO reviewers and signatories have never insisted on any demonstration of conformance to the Indian Standards. In recent months though, there has been on-going discussion from BIS, Department of Pharmaceuticals calling for strengthening of Indian standards. The CDSCO had also recently (Sep 2021) added a link to existing BIS standards on their website which shows that this may be indicative of their plan to implement Rule 7 and check for conformance to BIS Standards, if available.

Medical Device Registration Requirements in India

Currently only 38 types of medical devices are required to obtain an Import License (Form MD-15) from India’s Central Drugs Standard Control Organization (CDSCO) prior to being placed on the market.  On October 1, 2022 all risk Class A and B medical devices will require an Import License. The same requirement for all risk Class C and D medical devices comes into effect on October 1, 2022.  In the meantime, all non-Notified medical devices are required to be Registered.  Prerequisites for India medical device licensing include:

  1. reference country approval, and
  2. ISO 13458 certification of the manufacturing facility.

Given the reference country requirements, the registration process in India for imported devices is a re-assessment largely utilizing the same documentation and evidence required in the reference country review. For more information on the registration process in India, please click here.

Regulatory Alert:

All Class A and B Devices Require Import Licenses beginning October 1, 2022

All Class C and D beginning October 1, 2023

For the latest information on the regulatory process in India, please see our page on the topic here.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market.

Contact Asia Actual today with any questions on how these additional testing requirements may affect your market access to India.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.